-
76201-5X1MLThis certified reference material (CRM) is produced and certified in accordance with ISO/IEC 17025 and ISO 17034 . This CRM is traceable to primary material from an NMI, e.
-
1287008-200MGThis product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the
-
BP547This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the
-
F4381-10GFurosemide is a an ototoxic high-ceiling diuretic. Application Furosemide has been used: to investigate the influence of timing of dexamethasone administration on auditory hair cell survival in mice to study its effect on intracranial pressure
-
F4381-1GFurosemide is a an ototoxic high-ceiling diuretic. Application Furosemide has been used: to investigate the influence of timing of dexamethasone administration on auditory hair cell survival in mice to study its effect on intracranial pressure
-
F4381-25GFurosemide is a an ototoxic high-ceiling diuretic. Application Furosemide has been used: to investigate the influence of timing of dexamethasone administration on auditory hair cell survival in mice to study its effect on intracranial pressure
-
F4381-5GFurosemide is a an ototoxic high-ceiling diuretic. Application Furosemide has been used: to investigate the influence of timing of dexamethasone administration on auditory hair cell survival in mice to study its effect on intracranial pressure
-
1287020-50MGThis product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the
-
F-005-1MLFurosemide is a loop diuretic prescribed for treatment of edemas and congestive heart failure. In sports testing settings, furosemide is used as an illicit masking agent in the testing of performance-enhancing drugs.
-
A1720-1GChemical structure: aminoglycoside G-418 is an aminoglycoside antibiotic, which is produced by Micromonospora rhodorangea NRRL 5326 strain. It has a broad range of antibacterial activity both in vivo and in vitro .
-
A1720-25GChemical structure: aminoglycoside G-418 is an aminoglycoside antibiotic, which is produced by Micromonospora rhodorangea NRRL 5326 strain. It has a broad range of antibacterial activity both in vivo and in vitro .
-
A1720-5GChemical structure: aminoglycoside G-418 is an aminoglycoside antibiotic, which is produced by Micromonospora rhodorangea NRRL 5326 strain. It has a broad range of antibacterial activity both in vivo and in vitro .